Source: JBI Brazil - 2017 Conference of the Americas - Evidence Implementation. Conference titles: JBI Brazil - 2017 Conference of the Americas - Evidence Implementation. Unidade: EE
Subjects: HANSENÍASE, REVISÃO SISTEMÁTICA
ABNT
FERREIRA, Silvana M. Benevides et al. Rifampicin chemoprophylaxis to prevent leprosy: a systematic review of quantitative and qualitative evidence. 2017, Anais.. Campinas: Escola de Enfermagem, Universidade de São Paulo, 2017. Disponível em: https://doi.org/10.17648/jbi-2017. Acesso em: 09 nov. 2024.APA
Ferreira, S. M. B., Yonekura, T., Ignotti , E., Takahashi, J. A., Oliveira, L. B. de, & Soares, C. B. (2017). Rifampicin chemoprophylaxis to prevent leprosy: a systematic review of quantitative and qualitative evidence. In JBI Brazil - 2017 Conference of the Americas - Evidence Implementation. Campinas: Escola de Enfermagem, Universidade de São Paulo. doi:10.17648/jbi-2017NLM
Ferreira SMB, Yonekura T, Ignotti E, Takahashi JA, Oliveira LB de, Soares CB. Rifampicin chemoprophylaxis to prevent leprosy: a systematic review of quantitative and qualitative evidence [Internet]. JBI Brazil - 2017 Conference of the Americas - Evidence Implementation. 2017 ;[citado 2024 nov. 09 ] Available from: https://doi.org/10.17648/jbi-2017Vancouver
Ferreira SMB, Yonekura T, Ignotti E, Takahashi JA, Oliveira LB de, Soares CB. Rifampicin chemoprophylaxis to prevent leprosy: a systematic review of quantitative and qualitative evidence [Internet]. JBI Brazil - 2017 Conference of the Americas - Evidence Implementation. 2017 ;[citado 2024 nov. 09 ] Available from: https://doi.org/10.17648/jbi-2017